As Colorectal Cancer Awareness Month 2024 comes to a close, Further Together host Michael Holtz, a 12-year survivor of stage IIIB colorectal cancer, talks to Eric Mayer and Jessica Etheridge, CEO and director of marketing and branding, respectively, for Knoxville-based New Day Diagnostics. This March, New Day launched ColoHealth, a screening blood test for people at average risk of developing colorectal cancer. They talk about the importance of prevention and early detection, the rise in colorectal cancer rates among people under age 50, and the changing scientific landscape for early detection tests. Learn more at https://newdaydiagnostics.com/